Ivim Health reports hair loss from GLP-1 medications like Ozempic is typically temporary, linked to rapid weight loss, not ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

U.S. childhood and teen obesity rates have reached record-highs while adult obesity rates may be slowing, according to two ...

By Sriparna Roy and Juveria Tabassum Feb 18 (Reuters) - Global food and beverage companies from PepsiCo to Coca-Cola are ...

Ed Carlson, CVT, VTS (Nutrition), shares how routine body and muscle scoring, quantified nutrition histories, clear calorie ...

Tirzepatide is one of the drugs that has revolutionized the treatment of obesity and other conditions such as diabetes in recent years. Despite its clinical success, its precise molecular and cellular ...

“In the past, if I had lost weight, I got a self-esteem boost, which is almost like dopamine. It makes you crave sex more,” ...

Real-world data from 1,807 patients shows superior weight loss durability and 50% lower lean BOSTON, /PRNewswire/ -- knownwell, a comprehensive metabolic health company, released its inaugural ...

The AACE consensus statement emphasizes improvement of overall health in addition to weight reduction among adults with obesity and adiposity-based chronic disease.

Key market opportunities in the anti-obesity drugs sector include leveraging digital healthcare integration to enhance patient access and engagement, particularly in regions with limited specialist ...

The United Kingdom and Brazil have issued warnings about a possible link between GLP-1 weight-loss drugs and pancreatic ...